2009
DOI: 10.1016/j.ijcard.2008.10.002
|View full text |Cite
|
Sign up to set email alerts
|

The impact of mental illness on cardiac outcomes: A review for the cardiologist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
52
0
3

Year Published

2009
2009
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(57 citation statements)
references
References 134 publications
2
52
0
3
Order By: Relevance
“…Most antidepressants, even those with high antimuscarinic potency, such as paroxetine, are safe to use in high-risk cardiac populations, with few cardiac side-effects. 215 However, the increased risk of cardiac events in TCAs has previously been noted. 216 They are associated with increased heart rate, orthostatic hypotension, slow cardiac conduction, increased risk of arrhythmias, and a 2-fold relative risk of myocardial infarction.…”
Section: Effects Of Psychotropic Medication Use On Hrvmentioning
confidence: 99%
“…Most antidepressants, even those with high antimuscarinic potency, such as paroxetine, are safe to use in high-risk cardiac populations, with few cardiac side-effects. 215 However, the increased risk of cardiac events in TCAs has previously been noted. 216 They are associated with increased heart rate, orthostatic hypotension, slow cardiac conduction, increased risk of arrhythmias, and a 2-fold relative risk of myocardial infarction.…”
Section: Effects Of Psychotropic Medication Use On Hrvmentioning
confidence: 99%
“…[5][6][7] Recent data suggest that clinically significant anxiety can also affect outcomes including health-related quality of life in populations with cardiac disease. [5][6][7][8][9][10] Thus, there would be considerable clinical advantages to identifying clinical subpopulations at high risk for anxiety and/or depression who could benefit from interventions to decrease psychological distress. Proactively focusing on individuals with coronary artery disease (CAD) could serve to both decrease the risk of further cardiac events and improve outcomes for this population.…”
Section: Introductionmentioning
confidence: 99%
“…There is clinical evidence supporting the use of behavioral 32 and pharmacological interventions targeting depression to improve cardiovascular prognosis. 33,34 Given the well established relationship between depression and cardiovascular disease, 35 there needs to be a greater awareness of the role of depression as a cardiovascular risk factor in a normotensive population. In addition, longitudinal studies are needed to determine whether interventions aimed at decreasing depression have a positive impact on cardiovascular risk in a normotensive population.…”
Section: Discussionmentioning
confidence: 99%